AstraZeneca and Amgen drug Tezspire met the goals of a Phase 3 test in eosinophilic esophagitis (EoE), a chronic disorder ...

It’s time we reignite treatment development for sepsis and other immune-mediated conditions that strike when patients are most vulnerable.

Onos Health's Series A funding round was led by Costanoa, with support from Flare Capital Partners and CVS Health Ventures.

Employers expect healthcare costs to rise 9.2% in 2027 as they seek ways to curb rising hospital and pharmacy costs.

FDA approval of Revolution Medicines’ daraxonrasib, brand name Rasonque, makes the molecule the first RAS inhibitor approved ...

Epic faced an FTC antitrust probe this week, but that didn't stop the EHR giant from unveiling a wave of new AI tools at its ...

A new class action lawsuit accuses Oura of overstating its smart ring's sleep tracking accuracy, arguing the device relies on ...

Merck and Moderna said intismeran autogene, an mRNA cancer vaccine that prompts an immune response to proteins expressed by a ...

A pharmacy error at an Ascension hospital in Nashville left four joint replacement patients injected with potassium phosphate ...

SCAN is a non-profit Medicare Advantage insurer serving 460,000 members across California, Arizona, Nevada, Texas, New Mexico ...

Medical device giant Boston Scientific has disclosed a cyberattack that it says is disrupting its IT systems and business applications across the globe. Below are seven things to know about the ...

An ultra-rare disease whose standard of care for decades has been consuming a kitchen pantry staple every few hours now has its first FDA-approved therapy, an Ultragenyx Pharmaceutical genetic ...